Glucosamine
Market: Snapshot
The glucosamine
market may gain phenomenal growth across the assessment period of
2020-2030 on the back of the escalating cases of arthritis globally. In
addition, the heightening number of the obese populace may further strengthen
the growth rate of the glucosamine market during the forecast period.
According
to the Centers for Disease Control and Prevention (CDC), from the tenure of
2013-2015, nearly 54.4 mn adults in the U.S. had been told by the doctor that
they had some form of arthritis. The CDC also predicts that by the year 2040,
over 78 mn (26 percent) U.S. adults from the age of 18 and above will have
doctor-diagnosed arthritis. These statistics state the growing influence of
arthritis and the urgent need to cure it.
Obesity is
also a grave problem worldwide. According to the World Health Organization
(WHO), in 2016, more than 1.9 bn adults above 18 years of age were obese. These
numbers are expected to rise in the near future due to the rapidly changing
lifestyle. Hence, all these aspects indicate that the glucosamine market may
harness promising growth during the assessment period.
Glucosamine
is a compound that occurs naturally within the cartilage of the joints. It is
made from a blend of the chains of sugar and proteins. Glucosamine is generally
derived from the shells of the shellfish. It is available in the form of
capsules, powder, tablets, gel, and others. It is one of the most common
dietary supplements used across humans and pets too. Hence all these aspects
bring tremendous growth prospects for the glucosamine market.
Request Sample
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80129
This
report on the glucosamine market aids the stakeholder to overcome the barriers
of fake information and offers a detailed analysis of a plethora of segments.
The report provides the 3M (Market trends, Manufacturer analysis. Minute study
on regions) advantage to the stakeholder. This advantage proves to be a
game-changer for the stakeholder and assures ideal information on all aspects
surrounding the glucosamine market.
The report
focuses on the impact of the SARS-CoV-2 outbreak and also on the threats that
may harm the growth prospects of the glucosamine market. The scrutinized study
conducted by the researchers also highlights the opportunities and challenges
that the glucosamine market may face during the tenure of 2020-2030.
More
Trending Reports
Glucosamine
Market: Industrial Analysis
The
glucosamine market comprises a large number of players across the horizon. The
players are always involved in novel product launches and upgrades in
glucosamine to attract a massive consumer base. The players invest heavily in
research and development activities for discovering new formulations and
techniques that will make glucosamine more effective for the end-users.
The
players are involved in expansion activities for seamlessly catering to the
overwhelming demand. Some well-entrenched players in the glucosamine market are
Teva Pharmaceutical Industries Ltd., NOW Health Group, Inc., G.T.C. Union Group
Ltd., Mylan N.V., Health World Ltd., and Foodchem International Corporation.
Request
Covid19 analysis on this market
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80129
Glucosamine Market: Overwhelming Use across Various End-Uses
The
glucosamine market may gain great growth on the back of the rising cases of
obesity and arthritis. In addition to food supplements, glucosamine is also
used in cosmetics. Glucosamine is also used as a key ingredient in pet foods to
relieve aging dogs from joint pain. These factors may further invite immense
growth prospects for the glucosamine market.
Glucosamine Market: Regional Prospects
North
America’s glucosamine market may record exponential growth across the
assessment period of 2020-2030. The rising number of people consuming dietary
supplements is increasing rapidly. This aspect may prove to be a significant
growth factor for the glucosamine market in North America.
The common
use of glucosamine as an over-the-counter prescription drug in developed
countries across Europe may generate promising growth for the glucosamine
market. Thus, Europe may contribute to the growth of the glucosamine market to
a certain extent.
Buy Now
https://www.transparencymarketresearch.com/checkout.php?rep_id=80129<ype=S
Comments
Post a Comment